ERBB2 and breast cancer: We recently characterized the BTB in three experimental models of brain metastasis of breast cancer, triple-negative MDA-MB-231-BR617 (231-BR), HER2+ JIMT-1-BR318 (JIMT-1-BR), and HER2+ SUM190-BR319 (SUM190-BR).